Back to search

Peptide record

TPDB40726

CA4 Anticancer standard
35 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB40726
CA4
Anticancer
Cancer-related peptides
CancerPPD 2.0
standard
No
A 35-aa standard natural anticancer peptide sequence curated from CancerPPD 2.0, with an available 3D structural model.
Sequence
CGPCFTTDHNMARKCDECCGGKGRGKCFGPQCLCR
Physicochemical Analysis
C150H241N51O46S9
ISWYV
C
3783.42
8.10
7
3
5
+3
7.94
-0.566
14.00
Mammalian: 1.2 hour Yeast: >20 hour E.coli: >10 hour
500
13.22
12
Residue Composition
number
1
A
3
R
1
N
2
D
8
C
1
E
1
Q
6
G
1
H
0
I
1
L
3
K
1
M
2
F
2
P
0
S
2
T
0
W
0
Y
0
V
Amino Acid Distribution
A: 1 R: 3 N: 1 D: 2 C: 8 E: 1 Q: 1 G: 6 H: 1 I: 0 L: 1 K: 3 M: 1 F: 2 P: 2 S: 0 T: 2 W: 0 Y: 0 V: 0
Chemical Descriptors
35
C150H241N51O46S9
3783.42
8.10
+3
7.94
-0.566
Free
L
Linear
Free
Anticancer
Synthetic
Evidence Records 1 records
Evidence 1 Activity

Activity

Graph Figure 2
Anticancer

Target

Brain Tumor
U-251
Brain

Assay & Model

MTT assay
48-h

Source & Reference

CancerPPD 2.0
CancerPPD2
2016

Other

Source Activity Label Source Definition
Anticancer
CancerPPD 2.0 manually curated experimentally verified anticancer peptide/protein annotation.